พบ "Vaccines"ทั้งหมด 51 ผลลัพธ์
What criteria do decision makers in Thailand use to set priorities for vaccine introduction? (2016)
Siriporn Pooripussarakul1, Arthorn Riewpaiboon1* , David Bishai2, Charung Muangchana3 and Sripen Tantivess4
Abstract
Background: There is a need to identify rational criteria and set priorities for vaccines. In Thailand, many licensed vaccines are being considering for introduction into the Ex
Website warned over MMR claims
A website offering parents advice on vaccines has been ordered to remove information about the MMR jab after claiming it could be linked to autism.Babyjabs.co.uk said the three-in-one jab may be causing “up to 10%” of autism in children in the UK.But the Advertising Standards Authority ruled the cla
Vaccinology course – Ghana
This virtual workshop was provided for public health professionals, researchers, and policy makers from Ghana, Malawi, and Tanzania. The course covered topics such as political economy of vaccinology, vaccine policy and distribution, and the science of vaccines, with a specific focus on the COVID-19 pandemic and COVID-19 vaccines.
TRADE Talk: The beginning of new friendship between HITAP and GAVI
Health Intervention and Technology Assessment Program (HITAP) led by Dr. Yot Teerawattananon (3rd left), Founding Leader, and HITAP International Unit Staff, welcomed Dr. Seth Franklin Berkley (centre), CEO, Global Alliance for Vaccines and Immunizations (GAVI) on his visit to Thailand. Dr. Yot and
Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option
Abstract
Background
Due to competing health priorities and limited resources, many low-income countries, even those with a high disease burden, are not able to introduce pneumococcal conjugate vaccines.
Objective
To determine the cost-utility of 10- and 13-valent pneumococcal conjugate vacci
The beginning of new friendship between HITAP and GAVI
เว็บไซต์ : www.bangkokpost.comวันที่ 7 ธันวาคม พ.ศ. 2560 Health Intervention and Technology Assessment Program (HITAP) led by Dr. Yot Teerawattananon (3rd left), Founding Leader together with HITAP International Unit Staff, recently had an opportunity to welcome Dr. Seth Franklin Berkley (middle), C
Technical assistance to perform an economic analysis to assess the cost-effectiveness of introducing seasonal influenza vaccines
The Health Intervention and Technology Assessment Program (HITAP) International Unit (HIU), Thailand was contracted by the World Health Organization to provide technical support to two local Nepalese partners, namely the Center for Molecular Dynamics – Nepal (CMDN) and Nepal Health Economics Association (NHEA), to conduct an economic burden study
Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics. (2012)
Systematic Review of Economic Evaluations of Preparedness Strategies and Interventions against Influenza Pandemics.
Roma´n Pe´ rez Velasco1*, Naiyana Praditsitthikorn1, Kamonthip Wichmann1, Adun Mohara1, Surachai Kotirum1, Sripen Tantivess1, Constanza Vallenas2, Hande Harmanci2, Yot Teerawattanan
Stepping up the campaign Against cervical cancer
The debate over the price of the vaccine against HPV has become intense
http://www.bangkokpost.com/lifestyle/family/295534/stepping-up-the-campaign-against-cervical-cancerWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls be
Scientists see AIDS vaccine within reach after decades
(Reuters) – At an ill-fated press conference in 1984, U.S. Health and Human Services Secretary Margaret Heckler boldly predicted an effective AIDS vaccine would be available within just two years.But a string of failed attempts – punctuated by a 2007 trial in which a Merck vaccine appeared to make p
10 / หน้า